Table 2 of
Young, Mol Vis 2004;
10:163-176.Table 2 of
Young, Mol Vis 2004;
10:163-176.
Table 2. Extracellular matrix genes identified by microarray analysis
Extracellular matrix genes identified by microarray analysis with present calls in all 6 samples including GenBank Accession number, description of the expressed extracellular matrix gene, gene symbol, and published cytogenetic position.
GenBank accession Extracellular Cytogenetic number matrix description Symbol position --------- ------------------------------ -------- ------------- NM_001135 aggrecan 1 (chondroitin AGC1 15q26.1 sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122) NM_001135 NM_001723, 230/240 kDa BPAG1 6p12-p11 NM_001728 basigin (OK blood group) BSG 19p13.3 NM_000610 CD44 antigen (homing function CD44 11p13 and Indian blood group system) NM_000493 collagen, type X, alpha COL10A1 6q21-q22 1(Schmid metaphyseal chondrodysplasia) NM_001854 collagen, type XI, alpha 1 COL11A1 1p21 NM_001855 collagen, type XV, alpha 1 COL15A1 9q21-q22 NM_000089 collagen, type I, alpha 2 COL1A2 7q22.1 NM_000090 collagen, type III, alpha 1 COL3A1 2q31 (Ehlers-Danlos syndrome type IV, autosomal dominant) NM_001846 collagen, type IV, alpha 2 COL4A2 13q34 NM_000393 collagen, type V, alpha 2 COL5A2 2q14-q32 NM_001848 collagen, type VI, alpha 1 COL6A1 21q22.3 NM_001849 collagen, type VI, alpha 2 COL6A2 21q22.3 NM_004369 collagen, type VI, alpha 3 COL6A3 2q37 NM_001850 collagen, type VIII, alpha 1 COL8A1 3q12-q13.1 NM_001853 collagen, type IX, alpha 3 COL9A3 20q13.3 NM_000095 cartilage oligomeric matrix COMP 19p13.1 protein (pseudoachondroplasia, epiphyseal dysplasia 1, multiple) NM_004385 chondroitin sulfate CSPG2 5q14.3 proteoglycan 2 (versican) NM_001901 connective tissue growth CTGF 6q23.1 factor NM_004393 dystroglycan 1 DAG1 3p21 (dystrophin-associated glycoprotein 1) NM_004425 extracellular matrix protein 1 ECM1 1q21 NM_001393 extracellular matrix protein ECM2 9q22.3 2, female organ and adipocyte specific NM_004105 EGF-containing fibulin-like EFEMP1 2p16 extracellular matrix protein 1 NM_016938 EGF-containing fibulin-like EFEMP2 11q13 extracellular matrix protein 2 NM_006487 fibulin 1 FBLN1 22q13.31 NM_001998 fibulin 2 FBLN2 3p25-p24 NM_006329 fibulin 5 FBLN5 14q32.1 NM_000138 fibrillin 1 (Marfan syndrome) FBN1 15q21.1 NM_002023 fibromodulin FMOD 1q32 NM_002026 fibronectin 1 FN1 2q34 NM_002081 glypican 1 GPC1 2q35-q37 NM_004484 glypican 3 GPC3 Xq26.1 NM_000426 laminin, alpha 2 (merosin, LAMA2 6q22-q23 congenital muscular dystrophy) NM_000227 laminin, alpha 3 LAMA3 18q11.2 NM_002290 laminin, alpha 4 LAMA4 6q21 NM_005560 laminin, alpha 5 LAMA5 20q13.2-q13.3 NM_002291 laminin, beta 1 LAMB1 7q22 NM_002292 laminin, beta 2 (laminin S) LAMB2 3p21 NM_002293 laminin, gamma 1 (formerly LAMC1 1q31 LAMB2) NM_000428 latent transforming growth LTBP2 14q24 factor beta binding protein 2 NM_003573 latent transforming growth LTBP4 19q13.1-q13.2 factor beta binding protein 4 NM_002345 lumican LUM 12q21.3-q22 NM_005926 microfibrillar-associated MFAP1 15q15-q21 protein 1 NM_002404 microfibrillar-associated MFAP4 17p11.2 protein 4 NM_012215 meningioma expressed antigen 5 MGEA5 10q24.1-q24.3 (hyaluronidase) NM_000900 matrix Gla protein MGP 12p13.1-p12.3 NM_004530 matrix metalloproteinase 2 MMP2 16q13-q21 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase) NM_002422 matrix metalloproteinase 3 MMP3 11q22.3 (stromelysin 1, progelatinase) NM_002508 nidogen (enactin) NID 1q43 NM_007361 nidogen 2 (osteonidogen) NID2 14q21-q22 NM_000917 procollagen-proline, P4HA1 10q21.3-q23.1 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide I NM_004199 procollagen-proline, P4HA2 5q31 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide II NM_000918 procollagen-proline, P4HB 17q25 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase; thyroid hormone binding protein p55) NM_002593 procollagen C-endopeptidase PCOLCE 7q22 enhancer NM_000302 procollagen-lysine, PLOD 1p36.3-p36.2 2-oxoglutarate 5-dioxygenase (lysine hydroxylase, Ehlers-Danlos syndrome type VI) NM_002725 proline arginine-rich end PRELP 1q32 leucine-rich repeat protein NM_004587 ribosome binding protein 1 RRBP1 20p12 homolog 180 kDa (dog) NM_002639 serine (or cysteine) SERPINB5 18q21.3 proteinase inhibitor, clade B (ovalbumin), member 5 NM_000112 solute carrier family 26 SLC26A2 5q31-q34 (sulfate transporter), member 2 NM_003102 superoxide dismutase 3, SOD3 4p16.3-q21 extracellular NM_003118 secreted protein, acidic, SPARC 5q31.3-q32 cysteine-rich (osteonectin) NM_000582 secreted phosphoprotein 1 SPP1 4q21-q25 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) NM_003247 thrombospondin 2 THBS2 6q27 NM_003248 thrombospondin 4 THBS4 5q13 NM_003254 tissue inhibitor of TIMP1 Xp11.3-p11.23 metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor) NM_000362 tissue inhibitor of TIMP3 22q12.3 metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) NM_003278 tetranectin (plasminogen TNA 3p22-p21.3 binding protein) NM_002160 tenascin C (hexabrachion) TNC 9q33 |